VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 134 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,009,233 | +36.8% | 999,941 | +84.1% | 0.00% | 0.0% |
Q1 2024 | $9,510,381 | +14.4% | 543,140 | +42.3% | 0.00% | 0.0% |
Q4 2023 | $8,314,231 | +35.7% | 381,737 | -4.4% | 0.00% | +100.0% |
Q3 2023 | $6,124,956 | -18.4% | 399,280 | +26.5% | 0.00% | -50.0% |
Q2 2023 | $7,507,101 | -16.9% | 315,557 | -11.1% | 0.00% | 0.0% |
Q1 2023 | $9,028,910 | +26.9% | 354,910 | +45.6% | 0.00% | 0.0% |
Q4 2022 | $7,117,717 | +93764.1% | 243,674 | -34.1% | 0.00% | 0.0% |
Q3 2022 | $7,583 | -99.4% | 369,728 | +455.2% | 0.00% | – |
Q1 2022 | $1,231,000 | – | 66,598 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 3,882,671 | $50,513,550 | 3.22% |
Rosalind Advisors, Inc. | 300,000 | $3,903,000 | 3.00% |
Fairmount Funds Management LLC | 1,845,813 | $24,014,027 | 2.71% |
Ghost Tree Capital, LLC | 587,708 | $7,646,081 | 2.39% |
COMMODORE CAPITAL LP | 2,528,032 | $32,889,696 | 2.24% |
ACUTA CAPITAL PARTNERS, LLC | 199,433 | $2,594,623 | 2.18% |
5AM Venture Management, LLC | 736,595 | $9,583,101 | 2.14% |
Vivo Capital, LLC | 1,678,207 | $21,833,473 | 2.02% |
TANG CAPITAL MANAGEMENT LLC | 1,392,925 | $18,121,954 | 1.85% |
Kynam Capital Management, LP | 1,750,000 | $22,767,500 | 1.76% |